Short on Competition Act

Hozzl · 2025-07-31T04:23:21Z

Explore the details of Senate Bill 2345 Short on Competition Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

7/31/2025, 4:23 AM

Summary of Bill S 2345

The bill introduced in the 119th Congress with the title "A bill to allow for expedited approval of generic prescription drugs and temporary importation of prescription drugs in the case of marginally competitive drug markets and drug shortages" aims to expedite the approval process for generic prescription drugs and allow for the temporary importation of prescription drugs in instances of marginally competitive drug markets and drug shortages.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 2345

Bill S 2345 is currently in the status of Bill Introduced since July 17, 2025. Bill S 2345 was introduced during Congress 119 and was introduced to the Senate on July 17, 2025. Bill S 2345's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of July 17, 2025

Bipartisan Support of Bill S 2345

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 2345

Primary Policy Focus

Alternate Title(s) of Bill S 2345

A bill to allow for expedited approval of generic prescription drugs and temporary importation of prescription drugs in the case of marginally competitive drug markets and drug shortages.